The global fabry disease treatment market size is estimated to reach a value of USD 4.93 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.9% from 2024 to 2030. Rising cohort of Fabry disease, increasing adoption of novel therapies such as chaperone treatment, and potential approval of pipeline drugs including substrate reduction therapies...

Key Highlights of the Report: Worldwide Growing Cases of LAL-D disease: The growing incidence and prevalence of LAL-D disease is the major factor for increasing the demand for Lysosomal Acid Lipase Deficiency (LAL-D) Treatments. Increased Focus on Rare Disease Research: A key market trend in the Lysosomal Acid Lipase Deficiency (LAL-D) Treatment market is growing interest in research on rare...